Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma
This study has been completed.
Sponsor:
University of Chicago
Information provided by (Responsible Party):
Thomas Gajewski, University of Chicago
ClinicalTrials.gov Identifier:
NCT00203879
First received: September 12, 2005
Last updated: November 4, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2007 |
| Primary Completion Date: | May 2006 (Final data collection date for primary outcome measure) |